Medicine and Dentistry
Conjunctivitis
100%
Dupilumab
100%
Atopic Dermatitis
80%
Patient
60%
Clinician
40%
Biological Product
20%
Combination Therapy
20%
Clinical Feature
20%
Monoclonal Antibody
20%
Interleukin 13
20%
Interleukin 4
20%
Therapeutic Procedure
20%
Association
20%
Incidence
20%
Clinical Trial
20%
Side Effect
20%
Recognition
20%
Case Report
20%
INIS
conjunctivitis
100%
dermatitis
80%
patients
60%
risks
40%
management
40%
interleukins
40%
clinical trials
20%
therapy
20%
reviews
20%
side effects
20%
monoclonal antibodies
20%
Immunology and Microbiology
Conjunctivitis
100%
Dupilumab
100%
Atopic Dermatitis
80%
Biological Product
20%
Monoclonal Antibodies
20%
Interleukin 13
20%
Interleukin 4
20%
Association
20%
Incidence
20%
Recognition
20%